Clonidine for Sweating: What the 13-Patient Study Found

Clonidine sometimes appears on lists of medicines for excessive sweating. Before interpreting a percentage beside its name, check how many patients supplied that number and why others stopped treatment.

The response rate came from six people

A 2012 single-center chart review analyzed 59 patients receiving oral medicines for primary hyperhidrosis. Thirteen took clonidine: six responded, three did not, and four stopped because of effects related to decreased blood pressure. Six out of thirteen produced the 46% response rate.¹

The wider review excluded twelve patients lost to follow-up. It was retrospective, without placebo or randomized treatment assignment. Eleven clonidine recipients had facial/scalp or generalized sweating. Its results cannot establish a personal success probability or prove equal effectiveness to glycopyrrolate, despite no statistically significant difference between the small treatment groups.¹

Keep the count and outcome together when discussing this paper. “46% response” does not mean sweat production fell by 46%, and a study of thirteen recipients cannot precisely estimate uncommon harms.

This US tablet label is for hypertension

The US prescribing information reviewed here lists hypertension, not hyperhidrosis, as the indication. Prescribing these tablets for sweating is therefore an off-label use. The label describes reductions in blood pressure and heart rate, warns about sedation and dizziness, and cautions that alcohol or other sedating drugs can intensify sedation.²

Ask why clonidine is being considered for your sweating pattern and what benefit would justify continuing. Confirm which formulation the clinician proposes; a tablet study should not be treated as evidence for every clonidine product.

Decide how symptoms and medicines will be reviewed

UK patient guidance advises sitting or lying down if you feel dizzy on standing and speaking to your doctor straight away if you have fainted. Do not drive, cycle or operate machinery while dizzy or sleepy. Its UK urgent advice is to call a doctor or 111 for an irregular or unusually slow heartbeat.³

Take a complete medicine list to the prescribing appointment. The medicine-interaction guidance highlights combinations with blood-pressure or heart medicines, including beta blockers, digoxin, diltiazem and verapamil, that can lower blood pressure or slow the pulse too much. Sleeping tablets, some mental-health medicines and other products also require review.⁴

Ask the prescriber whether you need blood-pressure or pulse checks, when to take readings, and which symptoms or readings require contact. Get instructions tailored to your other medicines and usual blood pressure.

Plan a review before starting

The tablet label warns that stopping clonidine suddenly can cause a rapid rise in blood pressure. Do not devise a stopping schedule yourself. If adverse effects occur, contact the prescriber for instructions rather than treating abrupt withdrawal as the solution.²

Agree on a review date and a concrete sweating outcome, such as fewer shirt changes during a shift. Keep new dizziness or sleepiness beside the sweating notes so the appointment covers both benefit and tolerability.

Arms Up includes “The Step-Up Conversation,” which asks about the affected zone, previous attempts, trial comparisons, duration and adverse effects. Use it to prepare questions about the proposed medicine and the alternatives for your particular sweating pattern.